Frontiers
US$ 21.13
glucagon like peptide 1 glp 1 agonists GLP-1 receptor show promise in treating substance use disorders Current Insights, Advantages and Challenges
Description
95% CI, -0.02 to 0.03
Evaluate the benefits and concerns surrounding GLP-1 treatments
Ozempic and other GLP-1 receptor agonists have rapidly become some of the most talked-about medications in the management of type 2 diabetes and weight-relat...
Major market players have adopted organic and inorganic strategies, including partnerships and investments
95% CI: 0.581.14)
Grading of Recommendations Assessment, Development and Evaluation (GRADE) showed moderate certainty for MACE, all-cause death and hospitalization for HF
